Non ci sono recensioni
This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe.
Global Strategy for Influenza Viral Infection: What Is the Latest Information from WHO?
Pages 3-11
Imamura, Takeaki (et al.)
Epidemiology of Influenza with a Description of Recent Trends in Japan: What Are the Key Epidemiologic Features of Seasonal Influenza?
Pages 15-25
Arima, Yuzo (et al.)
Transmission of Influenza Virus in the Home: How Are They Transmitted in the Home?
Pages 27-36
Hirotsu, Nobuo
Cellular and Biochemical Pathogenic Processes in Severe Influenza Virus Infection: How Does Cytokine Storm Play a Role?
Pages 37-46
Kido, Hiroshi (et al.)
Pathology of Severe Influenza Virus Pneumonia: What Is the Importance of Alveolar Mouths?
Pages 47-55
Ohtsuki, Yuji (et al.)
Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What Are the Mechanisms of Secondary Bacterial Pneumonia?
Pages 57-65
Seki, Masafumi
Rapid Diagnosis of Influenza Viral Infection: What Are the Rapid Diagnostic Tests and Molecular Diagnosis?
Pages 69-77
Uno, Naoki (et al.)
Differential Diagnosis Between Influenza and Other Respiratory Viral Infections: What Are the Differential Diagnoses?
Pages 79-90
Kinjo, Takeshi (et al.)
Radiologic Findings of Influenza Pneumonia: What Are the Recent Radiological Findings?
Pages 91-99
Johkoh, Takeshi
Oral Findings of Influenza Viral Infection: What Are the Characteristic Pharyngeal Findings of Influenza?
Pages 101-103
Tamaki, Yuichiro
Classification of Pneumonia Complicated with Influenza Viral Infection: What Are the Patterns of Pneumonia?
Pages 107-114
Fujikura, Yuji
Influenza Encephalopathy: What Is Encephalopathy?
Pages 115-126
Tsuge, Mitsuru (et al.)
Treatment Guidelines for Influenza Virus Infection: What Does the Recent Guideline State?
Pages 129-136
Ishida, Tadashi
Treatment Strategy for Influenza Viral Infection in Adolescent: What Is the Current Adolescent Treatment?
Pages 137-147
Aoki, Yosuke
How to Use Anti-influenza Drugs: Zanamivir and Oseltamivir
Pages 149-159
Kawai, Naoki
How to Use Anti-influenza Drugs: Laninamivir Octanoate
Pages 161-169
Ikematsu, Hideyuki
How to Use Anti-influenza Drugs: Baloxavir Marboxil
Pages 171-179
Uehara, Takeki
How to Use Anti-influenza Drugs: Peramivir
Pages 181-190
Saisho, Yutaka
Prophylaxis of Influenza Viral Transmission: What Is the Current Prophylaxis?
Pages 191-197
Asai, Nobuhiro (et al.)
Influenza Vaccine Efficacy/Effectiveness: With Special Reference to Current Epidemiological Methodology
Pages 201-209
Fukushima, Wakaba
The New Anti-influenza Drug Baloxavir Marboxil: Can Influenza Viruses with Reduced Susceptibility to Baloxavir Maintain Viral Fitness?
Pages 211-219
Imai, Masaki (et al.)
Viruses Resistant to Oseltamivir or Baloxavir: What Do the Data Reveal About Resistance?
Pages 221-229
Takashita, Emi
Correction to: Influenza
Pages C1-C1
Sei sicuro di voler eseguire questa azione?